Illumina Ventures

Illumina Ventures is an independently managed venture capital firm specializing in genomics and precision health investments. The firm focuses on early-stage companies developing breakthrough science and technologies in life sciences tools, therapeutics, diagnostics, and personal wellness. Through its strategic partnership with Illumina, Inc., Illumina Ventures leverages deep technical and entrepreneurial expertise to support the development and acceleration of market-leading companies in the healthcare sector.

The firm's investment strategy encompasses a wide range of stages, from seed to pre-IPO, and spans various geographical regions, including the United States, Ireland, and the United Kingdom. Illumina Ventures' portfolio includes companies involved in life sciences tools, diagnostics, and personal wellness, with a particular emphasis on genomics, therapeutics, diagnostics, and personal wellness. The firm also invests in sectors such as life sciences tools, synthetic biology, molecular characterization, infectious disease diagnostics, single-cell analysis, spatial biology, and multi-omic profiling.

Through its Illumina Ventures Labs initiative, the firm provides a comprehensive support system for early-stage genomics startups. This includes access to capital, sequencing capabilities, mentorship, and fully equipped genomics lab facilities. By offering flexible financing options and technical expertise, Illumina Ventures Labs accelerates value creation from new company formation to Series A startups, capitalizing on Illumina Ventures' deep technical and entrepreneurial expertise to support the development and acceleration of early-stage breakthrough genomics startups.